HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regina H Silva Selected Research

Reserpine (Serpasil)

11/2022Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
1/2022Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats.
1/2022Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease.
1/2021Nociception alterations precede motor symptoms in a progressive model of parkinsonism induced by reserpine in middle-aged rats.
1/2021Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson's Disease.
1/2021Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.
1/2021Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
1/2019Serotonergic dysfunction in a model of parkinsonism induced by reserpine.
1/2019Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
1/2018Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Regina H Silva Research Topics

Disease

14Parkinson Disease (Parkinson's Disease)
10/2022 - 08/2008
10Parkinsonian Disorders (Parkinsonism)
11/2022 - 09/2013
9Catalepsy
10/2022 - 05/2012
6Memory Disorders (Memory Loss)
12/2022 - 05/2002
4Dyskinesias (Dyskinesia)
01/2017 - 05/2002
3Tardive Dyskinesia
01/2016 - 05/2002
2Sleep Deprivation
04/2006 - 11/2004
1Mental Disorders (Mental Disorder)
12/2022
1Inflammation (Inflammations)
10/2022
1Pain (Aches)
10/2022
1Weight Loss (Weight Reduction)
01/2022
1Neuroinflammatory Diseases
01/2022
1Body Weight (Weight, Body)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Movement Disorders (Movement Disorder)
01/2018
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2017
1Cognitive Dysfunction
01/2016
1Mood Disorders (Mood Disorder)
07/2015
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
04/2012
1Amnesia (Dissociative Amnesia)
07/2006

Drug/Important Bio-Agent (IBA)

21Reserpine (Serpasil)FDA Link
11/2022 - 05/2002
5Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2022 - 09/2013
3Dopamine (Intropin)FDA LinkGeneric
01/2022 - 01/2018
3Anti-Anxiety Agents (Anxiolytics)IBA
02/2019 - 11/2004
3Valproic Acid (Depakote)FDA LinkGeneric
05/2005 - 06/2003
3gamma-Aminobutyric Acid (GABA)IBA
05/2005 - 06/2003
2Volatile Oils (Essential Oils)IBA
10/2022 - 02/2019
2CyclodextrinsIBA
10/2022 - 02/2019
2SynucleinsIBA
10/2022 - 01/2017
2Neuroprotective AgentsIBA
10/2022 - 01/2017
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 04/2006
2CannabidiolIBA
01/2018 - 01/2016
2Levodopa (L Dopa)FDA LinkGeneric
01/2016 - 07/2015
2Therapeutic UsesIBA
05/2005 - 12/2004
2Topiramate (Topamax)FDA LinkGeneric
05/2005 - 12/2004
1Harmine (Telepathine)IBA
12/2022
1Hallucinogens (Psychedelics)IBA
12/2022
1AntioxidantsIBA
10/2022
1Proteins (Proteins, Gene)FDA Link
10/2022
1Testosterone PropionateFDA Link
01/2022
1Estrogens (Estrogen)FDA Link
01/2021
1Membrane LipidsIBA
02/2019
1PeroxidesIBA
02/2019
1Serotonin (5 Hydroxytryptamine)IBA
01/2019
1carvacrolIBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2017
1alpha-SynucleinIBA
01/2017
1Dopamine Agonists (Dopamine Agonist)IBA
07/2015
1Antidepressive Agents (Antidepressants)IBA
04/2012
1Scopolamine (Hyoscine)FDA Link
07/2006
1PhosphatidylserinesIBA
07/2006
1gaboxadol (THIP)IBA
05/2005
1Diazepam (Valium)FDA LinkGeneric
05/2005
1BaclofenFDA LinkGeneric
05/2005
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2004
1SolutionsIBA
12/2004
1Chlordiazepoxide (Elenium)FDA LinkGeneric
11/2004
1Clonidine (ST 155)FDA LinkGeneric
11/2004

Therapy/Procedure

2Injections
01/2021 - 01/2017
1Treatment Delay
10/2022
1Traditional Medicine (Folk Remedies)
10/2022
1Subcutaneous Injections
01/2019
1Drug Therapy (Chemotherapy)
01/2016